GlassScriptPhysician profile
Jonathan T Rice
NPI 1720113392
$7,679.28
in general payments reported to CMS, 2019-2025
40 companies · $1,112 in 2025
The $1,112 reported for 2025 was more than what 91% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,823 · 2022: $2,308 · 2023: $1,513 · 2024: $924 · 2025: $1,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,548.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $3,247.59 | 2021-2023 | Attrax, Pulse, Acp |
| Camber Spine Technologies LLC | $675.41 | 2022-2023 | |
| Globus Medical, INC. | $668.19 | 2023-2025 | Excelsius Gps, Xlif, Altera |
| Medtronic, INC. | $317.68 | 2021-2024 | Radialux, Intellis Adaptivestim, Aquamantys(Tm) |
| Merit Medical Systems INC | $284.44 | 2022-2025 | Stabilit System, Star Tumor Ablation System |
| Biotronik Nro, INC. | $237.61 | 2025 | Prospera |
| Radius Health, INC. | $186.27 | 2021-2024 | Tymlos |
| Arteriocyte Medical Systems, INC. | $167.87 | 2021-2025 | Magellan |
| Vertex Pharmaceuticals Incorporated | $151.44 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.04 | 2021-2022 | |
| Xtant Medical INC | $143.53 | 2024 | |
| Si-Bone, INC. | $137.98 | 2021-2022 | |
| Amgen INC. | $131.41 | 2021-2025 | Evenity, Prolia |
| Baxter Healthcare | $103.31 | 2021-2024 | Floseal |
| Orthofix Medical, INC. | $101.71 | 2024 | M6-C |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $91.25 | 2021-2025 | Proclaim |
| Nevro Corp. | $84.22 | 2023 | Senza |
| Painteq LLC | $83.60 | 2022 | |
| Grt US Holding, INC. | $77.06 | 2021-2022 | |
| Boston Scientific Corporation | $72.91 | 2024-2025 | General - Pain Management |
| Augmedics INC. | $61.13 | 2024 | Xvision |
| Stryker Corporation | $60.51 | 2022-2025 | Artix Mt |
| Ethicon US, LLC | $57.10 | 2021-2025 | Surgiflo Hemostatic Matrix |
| Surgalign Spine Technologies, INC. | $45.65 | 2022 | |
| Virtus Pharmaceuticals LLC | $38.64 | 2025 | Levorphanol Tartrate |
| Kowa Pharmaceuticals America, INC. | $32.51 | 2023 | Seglentis |
| Djo, LLC | $29.49 | 2024 | Aircast |
| Abbvie INC. | $27.90 | 2021 | |
| Integra Lifesciences Corporation | $24.55 | 2021 | |
| Arbor Pharmaceuticals, INC. | $24.29 | 2021 | |
| Vertos Medical, INC. | $23.25 | 2022 | |
| Collegium Pharmaceutical, INC. | $21.30 | 2024 | Belbuca |
| Curonix LLC | $21.09 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Innovation Technologies INC | $18.88 | 2022 | |
| Novo Nordisk INC | $17.05 | 2025 | Rybelsus, Ozempic |
| Saxum Surgical, INC. | $15.67 | 2023 | |
| Spinal Simplicity, LLC | $15.31 | 2021 | |
| Relievant Medsystems, INC. | $13.66 | 2023 | Intracept |
| Horizon Therapeutics Plc | $13.66 | 2022 | |
| Terumo Bct, INC. | $7.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.